UniProt ID | RHOA_HUMAN | |
---|---|---|
UniProt AC | P61586 | |
Protein Name | Transforming protein RhoA | |
Gene Name | RHOA | |
Organism | Homo sapiens (Human). | |
Sequence Length | 193 | |
Subcellular Localization |
Cell membrane Lipid-anchor Cytoplasmic side. Cytoplasm, cytoskeleton. Cleavage furrow. Cytoplasm, cell cortex . Midbody. Cell projection, lamellipodium. Localized to cell-cell contacts in calcium-treated keratinocytes (By similarity). Translocates |
|
Protein Description | Regulates a signal transduction pathway linking plasma membrane receptors to the assembly of focal adhesions and actin stress fibers. Involved in a microtubule-dependent signal that is required for the myosin contractile ring formation during cell cycle cytokinesis. Plays an essential role in cleavage furrow formation. Required for the apical junction formation of keratinocyte cell-cell adhesion. Stimulates PKN2 kinase activity. May be an activator of PLCE1. Activated by ARHGEF2, which promotes the exchange of GDP for GTP. Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly. The MEMO1-RHOA-DIAPH1 signaling pathway plays an important role in ERBB2-dependent stabilization of microtubules at the cell cortex. It controls the localization of APC and CLASP2 to the cell membrane, via the regulation of GSK3B activity. In turn, membrane-bound APC allows the localization of the MACF1 to the cell membrane, which is required for microtubule capture and stabilization. Regulates a signal transduction pathway linking plasma membrane receptors to the assembly of focal adhesions and actin stress fibers. Involved in a microtubule-dependent signal that is required for the myosin contractile ring formation during cell cycle cytokinesis. Plays an essential role in cleavage furrow formation. Required for the apical junction formation of keratinocyte cell-cell adhesion. May be an activator of PLCE1. Activated by ARHGEF2, which promotes the exchange of GDP for GTP. Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly. The MEMO1-RHOA-DIAPH1 signaling pathway plays an important role in ERBB2-dependent stabilization of microtubules at the cell cortex. It controls the localization of APC and CLASP2 to the cell membrane, via the regulation of GSK3B activity. In turn, membrane-bound APC allows the localization of the MACF1 to the cell membrane, which is required for microtubule capture and stabilization (By similarity). Regulates KCNA2 potassium channel activity by reducing its location at the cell surface in response to CHRM1 activation; promotes KCNA2 endocytosis. [PubMed: 9635436] | |
Protein Sequence | MAAIRKKLVIVGDGACGKTCLLIVFSKDQFPEVYVPTVFENYVADIEVDGKQVELALWDTAGQEDYDRLRPLSYPDTDVILMCFSIDSPDSLENIPEKWTPEVKHFCPNVPIILVGNKKDLRNDEHTRRELAKMKQEPVKPEEGRDMANRIGAFGYMECSAKTKDGVREVFEMATRAALQARRGKKKSGCLVL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
6 | Ubiquitination | --MAAIRKKLVIVGD --CCCCCCEEEEECC | 44.33 | - | |
7 | Ubiquitination | -MAAIRKKLVIVGDG -CCCCCCEEEEECCC | 37.83 | - | |
16 | S-palmitoylation | VIVGDGACGKTCLLI EEECCCCCCCEEEEE | 7.60 | 29575903 | |
19 | Phosphorylation | GDGACGKTCLLIVFS CCCCCCCEEEEEEEE | 8.15 | 19060867 | |
26 | Phosphorylation | TCLLIVFSKDQFPEV EEEEEEEECCCCCCE | 25.16 | 19060867 | |
27 | Sumoylation | CLLIVFSKDQFPEVY EEEEEEECCCCCCEE | 44.05 | - | |
34 | Phosphorylation | KDQFPEVYVPTVFEN CCCCCCEECCCEECC | 10.07 | 23532336 | |
34 | O-linked_Glycosylation | KDQFPEVYVPTVFEN CCCCCCEECCCEECC | 10.07 | 24141704 | |
34 | Nitration | KDQFPEVYVPTVFEN CCCCCCEECCCEECC | 10.07 | - | |
34 | AMPylation | KDQFPEVYVPTVFEN CCCCCCEECCCEECC | 10.07 | 19362538 | |
34 | O-AMP-tyrosine | KDQFPEVYVPTVFEN CCCCCCEECCCEECC | 10.07 | - | |
37 | O-AMP-threonine | FPEVYVPTVFENYVA CCCEECCCEECCEEE | 27.99 | - | |
37 | Phosphorylation | FPEVYVPTVFENYVA CCCEECCCEECCEEE | 27.99 | 25106551 | |
37 | O-linked_Glycosylation | FPEVYVPTVFENYVA CCCEECCCEECCEEE | 27.99 | 7775453 | |
37 | AMPylation | FPEVYVPTVFENYVA CCCEECCCEECCEEE | 27.99 | 19039103 | |
41 | ADP-ribosylation | YVPTVFENYVADIEV ECCCEECCEEEEEEE | 25.72 | 1328215 | |
41 | ADP-ribosylation | YVPTVFENYVADIEV ECCCEECCEEEEEEE | 25.72 | - | |
42 | Phosphorylation | VPTVFENYVADIEVD CCCEECCEEEEEEEC | 6.99 | - | |
60 | Phosphorylation | VELALWDTAGQEDYD EEEEEEECCCCCCHH | 22.55 | 29978859 | |
63 | Serotonylation | ALWDTAGQEDYDRLR EEEECCCCCCHHHCC | 37.61 | - | |
66 | Phosphorylation | DTAGQEDYDRLRPLS ECCCCCCHHHCCCCC | 11.38 | 25884760 | |
73 | Phosphorylation | YDRLRPLSYPDTDVI HHHCCCCCCCCCCEE | 36.98 | - | |
88 | Phosphorylation | LMCFSIDSPDSLENI EEEEECCCCHHHHCC | 29.01 | - | |
100 | Phosphorylation | ENIPEKWTPEVKHFC HCCCCCCCHHHHHHC | 22.19 | - | |
104 | Ubiquitination | EKWTPEVKHFCPNVP CCCCHHHHHHCCCCC | 29.33 | 21890473 | |
104 | Ubiquitination | EKWTPEVKHFCPNVP CCCCHHHHHHCCCCC | 29.33 | 21890473 | |
107 | S-palmitoylation | TPEVKHFCPNVPIIL CHHHHHHCCCCCEEE | 2.10 | 29575903 | |
118 | Ubiquitination | PIILVGNKKDLRNDE CEEEECCHHHHCCCH | 41.56 | - | |
119 | Methylation | IILVGNKKDLRNDEH EEEECCHHHHCCCHH | 67.03 | 23644510 | |
119 | Ubiquitination | IILVGNKKDLRNDEH EEEECCHHHHCCCHH | 67.03 | - | |
128 | Methylation | LRNDEHTRRELAKMK HCCCHHHHHHHHHHH | 31.80 | 115491229 | |
133 | Ubiquitination | HTRRELAKMKQEPVK HHHHHHHHHHCCCCC | 60.29 | 21890473 | |
135 | Ubiquitination | RRELAKMKQEPVKPE HHHHHHHHCCCCCCH | 51.29 | 21890473 | |
135 | Acetylation | RRELAKMKQEPVKPE HHHHHHHHCCCCCCH | 51.29 | 26051181 | |
140 | Ubiquitination | KMKQEPVKPEEGRDM HHHCCCCCCHHCCCH | 58.38 | 21890473 | |
156 | Phosphorylation | NRIGAFGYMECSAKT HHHCCCEEEECCCCC | 5.36 | 28152594 | |
157 | Sulfoxidation | RIGAFGYMECSAKTK HHCCCEEEECCCCCC | 4.24 | 21406390 | |
159 | Glutathionylation | GAFGYMECSAKTKDG CCCEEEECCCCCCCH | 2.46 | 22555962 | |
159 | S-nitrosylation | GAFGYMECSAKTKDG CCCEEEECCCCCCCH | 2.46 | 2212679 | |
160 | Phosphorylation | AFGYMECSAKTKDGV CCEEEECCCCCCCHH | 21.35 | 28152594 | |
162 | Ubiquitination | GYMECSAKTKDGVRE EEEECCCCCCCHHHH | 39.55 | - | |
162 | Acetylation | GYMECSAKTKDGVRE EEEECCCCCCCHHHH | 39.55 | 25953088 | |
164 | Ubiquitination | MECSAKTKDGVREVF EECCCCCCCHHHHHH | 52.34 | - | |
173 | Sulfoxidation | GVREVFEMATRAALQ HHHHHHHHHHHHHHH | 2.91 | 30846556 | |
188 | Phosphorylation | ARRGKKKSGCLVL-- HHCCCCCCCCEEC-- | 43.55 | 15890975 | |
190 | Geranylgeranylation | RGKKKSGCLVL---- CCCCCCCCEEC---- | 2.83 | - | |
190 | Methylation | RGKKKSGCLVL---- CCCCCCCCEEC---- | 2.83 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
34 | Y | Phosphorylation | Kinase | BCR-ABL1 | A9UF07 | PSP |
34 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
42 | Y | Phosphorylation | Kinase | MET | P08581 | PSP |
66 | Y | Phosphorylation | Kinase | BCR-ABL1 | A9UF07 | PSP |
66 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
88 | S | Phosphorylation | Kinase | MAPK3 | P27361 | GPS |
100 | T | Phosphorylation | Kinase | MAPK3 | P27361 | GPS |
188 | S | Phosphorylation | Kinase | PKACA | P17612 | PSP |
188 | S | Phosphorylation | Kinase | PRKACA | P05132 | GPS |
188 | S | Phosphorylation | Kinase | PKG1 | Q13976 | PSP |
188 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
188 | S | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
- | K | Ubiquitination | E3 ubiquitin ligase | KCTD13 | Q8WZ19 | PMID:19782033 |
- | K | Ubiquitination | E3 ubiquitin ligase | TNFAIP1 | Q13829 | PMID:19782033 |
- | K | Ubiquitination | E3 ubiquitin ligase | SMURF2 | Q9HAU4 | PMID:21402695 |
- | K | Ubiquitination | E3 ubiquitin ligase | FBXL19 | Q6PCT2 | PMID:24658274 |
- | K | Ubiquitination | E3 ubiquitin ligase | SMURF1 | Q9HCE7 | PMID:14657501 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RHOA_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"cGMP-dependent protein kinase phosphorylates and inactivates RhoA."; Sawada N., Itoh H., Yamashita J., Doi K., Inoue M., Masatsugu K.,Fukunaga Y., Sakaguchi S., Sone M., Yamahara K., Yurugi T., Nakao K.; Biochem. Biophys. Res. Commun. 280:798-805(2001). Cited for: PHOSPHORYLATION AT SER-188 BY PRKG1. | |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-156, AND MASSSPECTROMETRY. |